Literature DB >> 33643721

The Impact of Door to Diuretic Time in Acute Heart Failure on Hospital Length of Stay and In-Patient Mortality.

Arshad Muhammad Iqbal1,2, Sohaib K Mohammed3, Nida Zubair4, Ateeq Mubarik5,6,7, Adnan Ahmed8, Syed Farrukh Jamal9, Syed Moin Hassan10, Furqan Haq11, Salman Muddassir1.   

Abstract

Background Acute heart failure (AHF) can be life-threatening if not treated promptly and can significantly increase the number of annual emergency department (ED) encounters in the United States. Achieving adequate and prompt euvolemic state in AHF patients using intravenous (IV) diuretics is the cornerstone of treatment, which not only reduces in-hospital stay and mortality but also decreases healthcare expenditures. Surprisingly, the door to diuretic (D2D) time in AHF patients has always been a debatable issue among physicians worldwide, and so far, there are no set guidelines. This study examines a large cohort of AHF patients to determine the association between diuretics use within 90 minutes of ED admission and hospital length of stay (LOS) and patient mortality.  Methods Retrospective institutional data of AHF patients receiving IV diuretics following ED admission were extracted from 2016 to 2017. A total of 7,751 patients treated for AHF exacerbation were included, which were further divided into two groups based on the timing of diuretics administration (<90 minutes vs. ≥90 minutes). The primary outcomes were LOS between the two groups and hospital mortality. The standard statistical methodology was used for data analysis. Results  A total of 7,751 AHF cases receiving IV diuretics were identified. Almost 1,432 patients (18.5%) received IV diuretics within 90 minutes of ER admission (group 1) while 6,319 patients (81.5%) patients received IV diuretics after 90 minutes (group 2). Furthermore, among group 1 patients, average LOS was noted to be associated with shorter hospitalization (average of 1.423 days less as compared to group 2 patients (confidence interval (CI) =1.02-1.82; p<0.05). Finally, after controlling for other mortality risk factors, patients in group 2 were 1.435 times more likely to have died compared to patients in group 1 (CI=1.03-1.98; p<0.05). Conclusions  D2D time in AHF patients has always been a crucial judgmental decision. The current study successfully demonstrated the relation between IV diuretics administration within 90 minutes of ED admission, favorable clinical outcomes, and decreased mortality rates. More adequately powered studies are needed to validate the results of our current study further.
Copyright © 2021, Iqbal et al.

Entities:  

Keywords:  acute decompensated heart failure; door to diuretic time; length of hospital stay (los); mortality

Year:  2021        PMID: 33643721      PMCID: PMC7884126          DOI: 10.7759/cureus.12742

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  12 in total

1.  Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2015-12-16       Impact factor: 29.690

2.  National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008.

Authors:  Jersey Chen; Sharon-Lise T Normand; Yun Wang; Harlan M Krumholz
Journal:  JAMA       Date:  2011-10-19       Impact factor: 56.272

Review 3.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

4.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur J Heart Fail       Date:  2016-05-20       Impact factor: 15.534

5.  The Effect of Door-to-Diuretic Time on Clinical Outcomes in Patients With Acute Heart Failure.

Authors:  Jin Joo Park; Sun-Hwa Kim; Il-Young Oh; Dong-Ju Choi; Hyun-Ah Park; Hyun-Jai Cho; Hae-Young Lee; Jae-Yeong Cho; Kye Hun Kim; Jung-Woo Son; Byung-Su Yoo; Jaewon Oh; Seok-Min Kang; Sang Hong Baek; Ga Yeon Lee; Jin Oh Choi; Eun-Seok Jeon; Sang Eun Lee; Jae-Joong Kim; Ju-Hee Lee; Myeong-Chan Cho; Se Yong Jang; Shung Chull Chae; Byung-Hee Oh
Journal:  JACC Heart Fail       Date:  2018-04       Impact factor: 12.035

6.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Theresa McDonagh; Udo Sechtem; Luis Almenar Bonet; Panayiotis Avraamides; Hisham A Ben Lamin; Michele Brignole; Antonio Coca; Peter Cowburn; Henry Dargie; Perry Elliott; Frank Arnold Flachskampf; Guido Francesco Guida; Suzanna Hardman; Bernard Iung; Bela Merkely; Christian Mueller; John N Nanas; Olav Wendelboe Nielsen; Stein Orn; John T Parissis; Piotr Ponikowski
Journal:  Eur J Heart Fail       Date:  2012-08       Impact factor: 15.534

7.  Improving care for patients with acute heart failure: before, during and after hospitalization.

Authors:  Martin R Cowie; Stefan D Anker; John G F Cleland; G Michael Felker; Gerasimos Filippatos; Tiny Jaarsma; Patrick Jourdain; Eve Knight; Barry Massie; Piotr Ponikowski; José López-Sendón
Journal:  ESC Heart Fail       Date:  2015-01-21

8.  Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.

Authors:  Yuya Matsue; Kevin Damman; Adriaan A Voors; Nobuyuki Kagiyama; Tetsuo Yamaguchi; Shunsuke Kuroda; Takahiro Okumura; Keisuke Kida; Atsushi Mizuno; Shogo Oishi; Yasutaka Inuzuka; Eiichi Akiyama; Ryuichi Matsukawa; Kota Kato; Satoshi Suzuki; Takashi Naruke; Kenji Yoshioka; Tatsuya Miyoshi; Yuichi Baba; Masayoshi Yamamoto; Koji Murai; Kazuo Mizutani; Kazuki Yoshida; Takeshi Kitai
Journal:  J Am Coll Cardiol       Date:  2017-06-27       Impact factor: 24.094

9.  Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.

Authors:  Alan S Maisel; William F Peacock; N McMullin; Robert Jessie; Gregg C Fonarow; Janet Wynne; Roger M Mills
Journal:  J Am Coll Cardiol       Date:  2008-08-12       Impact factor: 24.094

Review 10.  Acute Heart Failure: Definition, Classification and Epidemiology.

Authors:  Sameer Kurmani; Iain Squire
Journal:  Curr Heart Fail Rep       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.